Paricalcitol solution
Paricalcitol solution is mainly composed of Paricalcitol (HY-50919). Paricalcitol, a vitamin D analogue, is a vitamin D receptor agonist, used for the prevention and treatment of secondary hyperparathyroidism (excessive secretion of parathyroid hormone) associated with chronic renal failure.
For research use only. We do not sell to patients.
- CAS No.: 131918-61-1
- Formula: C27H44O3
- Molecular Weight:416.64
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
Chemical Information
-
CAS No. 131918-61-1
-
Molecular Weight 416.64
-
Formula C27H44O3
-
SMILES
C[C@@]1(CCC/C2=C\C=C3C[C@H](C[C@@H](C/3)O)O)[C@]([H])(CC[C@]12[H])[C@@H](/C=C/[C@@H](C(C)(O)C)C)C
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
[1]. Martinez-Moreno JM, et al. In vascular smooth muscle cells paricalcitol prevents phosphate-induced Wnt/beta-catenin activation. Am J Physiol Renal Physiol. 2012 Aug 8. [Content Brief]
[2]. Meems LM, et al. The vitamin D receptor activator paricalcitol prevents fibrosis and diastolic dysfunction in a murine model of pressure overload. J Steroid Biochem Mol Biol. 2012 Jul 16;132(3-5):282-289. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)